Bioventus Inc. Class A Common Stock (NASDAQ: BVS) last traded at $14.38, up 0.35% on the session. The quote above updates while this page is open; the figures below are drawn from Bioventus Inc. Class A Common Stock’s own filings and are restated only when a new one is published.
Bioventus Inc. Class A Common Stock trades on NASDAQ under the ticker BVS. Its market capitalisation is $1.02 billion.
Valuation measures for Bioventus Inc. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.02B |
|---|---|
| Enterprise value | $1.39B |
| P/E ratio | 18.68 |
| Price / sales | 1.75 |
| Price / book | 4.46 |
| Beta | 0.59 |
Trailing-twelve-month figures tagged in Bioventus Inc. Class A Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $581.85M |
|---|---|
| Net income (TTM) | $54.46M |
| EPS (TTM) | $0.770 |
| Gross margin | 68.65% |
| Operating margin | 10.02% |
| Return on equity | 23.86% |
| Cash | $29.46M |
Range and volume for BVS over the past 52 weeks.
| 52-week high | $15.89 |
|---|---|
| 52-week low | $6.26 |
| Volume | 745.1K |
| Average volume | 755.7K |
| Previous close | $14.33 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.